Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Recurrence × Positron Emission Tomography Computed Tomography × Clear all

Sponsor

Conditions

Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Multiple Pulmonary Nodules 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Hodgkin Disease 1 Hepatic Malignancies 1 Head and Neck Neoplasms 1 Glioblastoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Cancer Diagnosis 1 Breast Cancer Metastases 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 32 Dexamethasone 30 Rituximab 22 Cytarabine 21 fludarabine phosphate 20 Methotrexate 17 Lenalidomide 17 fludarabine 15 Bortezomib 15 Peripheral Blood Stem Cell Transplantation 14 Calcium Dobesilate 14 Whole-Body Irradiation 13 Mycophenolic Acid 13 Etoposide 13 pembrolizumab 12 Melphalan 12 Filgrastim 12 Paclitaxel 11 Gemcitabine 11 Cyclosporine 11 Carboplatin 11 pomalidomide 10 Busulfan 10 Vincristine 9 carfilzomib 8 Tacrolimus 8 Panobinostat 8 Clofarabine 8 Cetuximab 8 Brentuximab Vedotin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡